Netherlands· NL-9b12bc93e103
Fluvoxaminemaleaat 50 mg, tabletten
A fluvoxamine product containing fluvoxaminewaterstofmaleaat, registered in Netherlands by Genthon B.V.. The same ATC class is registered in 17 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Fluvoxamine is registered in 17 of 19 countries.
Countries holding a registration under ATC N06AB08 (fluvoxamine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 10 of them publish a price we can compare per daily dose
Fluvoxamine · ATC N06AB08
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fluvoxamine costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.25 in France to $1.43 in Switzerland — a ×5.6 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Fluvoxamine · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.43
- IT Italy$0.40
- ES Spain$0.29
- FR France$0.25
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- FLUVOXAMINEWATERSTOFMALEAAT
- Manufacturer
- Genthon B.V.
- Country
- Netherlands (NL)
- ATC code
- N06AB08
- ATC class
- Fluvoxamine
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id20579
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
450 interactions on record for fluvoxamine.
Graded by severity as the source publishes them — 38 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fluvoxamine · interactions on record
450 records
- 38 severe
- 313 moderate
- 8 minor
- 14 info
Most severe, free to view
- AlosetronA03AE01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
77 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fluvoxamine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandFevarinAbbott Healthcare Products B.V
- FranceFLOXYFRAL 50 mg, comprimé pelliculé sécableVIATRIS MEDICAL
- PolandFevarinInPharm Sp. z o.o.
- SwitzerlandFloxyfral Junior
- CzechiaFEVARINVIATRIS HEALTHCARE LIMITED, Dublin
- SpainDUMIROX 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULAViatris Healthcare Limited
- NorwayFevarinViatris AS
- United StatesFluvoxamine maleateUpsher-Smith Laboratories, LLC
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Floxyfral
- Belgium · Floxyfral, Fluvoxamine Eg
- Bulgaria · Феварин
- Cyprus · Faverin
- Czechia · Fevarin
- Germany · Fevarin, Fluvoxamin Neuraxpharm
- Estonia · Fevarin
- Spain · Dumirox, Fluvoxamina Sandoz
- Finland · Fluvosol
- France · Floxyfral, Fluvoxamine Arrow
- United Kingdom (Northern Ireland) · Faverin, Fluvoxamine Tillomed Laboratories
- Greece · Dumyrox
- Croatia · Fevarin
- Hungary · Fevarin
- Ireland · Faverin
- Italy · Dumirox, Fevarin
- Lithuania · Fevarin
- Luxembourg · Floxyfral, Fluvoxamine Eg
- Latvia · Fevarin
- Malta · Dumyrox
- Norway · Fevarin
- Poland · Fevarin
- Portugal · Dumyrox, Fluvoxamina Generis
- Romania · Fevarin
- Sweden · Fevarin
- Slovakia · Fevarin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a79fc0a6-2e9a-4b54-94cc-d28548a9f235 GET /v1/drugs/a79fc0a6-2e9a-4b54-94cc-d28548a9f235?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h20579_smpc.pdf",
"strength": null,
"atc_label": "Fluvoxamine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg20579",
"excipients": [
"HYPROMELLOSE (E 464)",
"MACROGOL",
"MANNITOL (D-) (E 421)",
"MAÏSZETMEEL",
"NATRIUMSTEARYLFUMARAAT",
"SILICIUMDIOXIDE (E 551)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)",
"ZETMEEL, GEPREGELATINEERD"
],
"substances": [
"FLUVOXAMINEWATERSTOFMALEAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h20579.pdf",
"authorised_at": "1997/08/15",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "20579",
"additional_monitoring": "N"
}See everything about fluvoxamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.